Informationen:
Fehler:
ID
17396
Beschreibung
Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC; ODM derived from: https://clinicaltrials.gov/show/NCT00786331
Link
https://clinicaltrials.gov/show/NCT00786331
Stichworte
Versionen (1)
- 11.09.16 11.09.16 -
Hochgeladen am
11. September 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Advanced Non-Small Cell Lung Cancer NCT00786331
Eligibility Advanced Non-Small Cell Lung Cancer NCT00786331
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Advanced Non-Small Cell Lung Cancer NCT00786331
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
written informed consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
non-small-cell lung cancer
Item
histologically or cytologically confirmed non-small-cell lung cancer
boolean
C0007131 (UMLS CUI [1])
metastatic disease
Item
unresectable stage iiib, stage iv and unresectable local relapse or metastatic disease, with evidence of disease progression after first line chemotherapy which should have included a platinum agent.
boolean
C0027627 (UMLS CUI [1])
ecog
Item
ecog performance status lower than or equal to 2
boolean
C1520224 (UMLS CUI [1])
hepatic and renal functions
Item
adequate hematological, hepatic and renal functions
boolean
C0232805 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0232741 (UMLS CUI [2])
life expectancy
Item
life expectancy greater than or equal to 12 weeks
boolean
C0023671 (UMLS CUI [1])
chemotherapy regimen
Item
prior treatment with only 1 chemotherapy regimen for the treatment of advanced disease which should have included a platinum agent
boolean
C0392920 (UMLS CUI [1])
measurable target lesion
Item
at baseline, presence of at least one measurable target lesion as per recist criteria
boolean
C1513041 (UMLS CUI [1])
pemetrexed
Item
prior treatment with pemetrexed.
boolean
C0210657 (UMLS CUI [1])
pregnant or lactating
Item
patients who are pregnant or lactating
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
C0006147 (UMLS CUI [1,2])
medical condition
Item
patients with any underlying medical condition that might be aggravated by treatment or which cannot be controlled.
boolean
C0012634 (UMLS CUI [1])
brain metastases
Item
symptomatic brain metastases
boolean
C0220650 (UMLS CUI [1])
malignancy
Item
history of another malignancy within the past five years except basal cell carcinoma of the skin or carcinoma in situ of the cervix.
boolean
C0006826 (UMLS CUI [1])
concomitant treatment
Item
concomitant treatment with any other anticancer drug.
boolean
C1707479 (UMLS CUI [1])